<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-28-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>0930-AA14</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>200904</PUBLICATION_ID>
            <PUBLICATION_TITLE>Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>0930</CODE>
            <NAME>Substance Abuse and Mental Health Services Administration</NAME>
            <ACRONYM>SAMHSA</ACRONYM>
        </AGENCY>
        <PARENT_AGENCY>
            <CODE>0900</CODE>
            <NAME>Department of Health and Human Services</NAME>
            <ACRONYM>HHS</ACRONYM>
        </PARENT_AGENCY>
        <RULE_TITLE>Opioid Drugs in Maintenance or Detoxification Treatment of Opiate Addition</RULE_TITLE>
        <ABSTRACT><![CDATA[This proposed rule, when finalized will modify the regulatory dispensing restrictions under 42 CFR part 8 for the drug substance buprenorphine.  This medication is used to treat kersin and other opioid addiction.]]></ABSTRACT>
        <PRIORITY_CATEGORY>Other Significant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Proposed Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <RFA_SECTION_610_REVIEW>Section 610 Review</RFA_SECTION_610_REVIEW>
        <CFR_LIST>
            <CFR>42 CFR 8-12</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>21 USC 823 (9)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 257a</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 290aa(d)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 290dd-2</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 300xx-23</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 300x-27(a)</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 300y-11</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>09/00/2009</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <PRINT_PAPER>Yes</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Nicholas</FIRST_NAME>
                <LAST_NAME>Reuter</LAST_NAME>
                <TITLE>Supervising Public Health Advisor</TITLE>
                <AGENCY>
                    <CODE>0930</CODE>
                    <NAME>Substance Abuse and Mental Health Services Administration</NAME>
                    <ACRONYM>SAMHSA</ACRONYM>
                </AGENCY>
                <PHONE>240 276-2716</PHONE>
                <EMAIL>nicholas.reuter@samhsa.hhs.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Suite 2-1063, One Choke Cherry Road,</STREET_ADDRESS>
                    <CITY>Rockville</CITY>
                    <STATE>MD</STATE>
                    <ZIP>20857</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
